Distinguished in Liver Failure

Christophe Bureau

CHU Caen
Caen, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Liver Failure
CHU Caen
Caen, FR 
OverviewLocationsClinical Research

Overview

Christophe Bureau practices in Caen, France. Mr. Bureau is rated as a Distinguished expert by MediFind in the treatment of Liver Failure. His top areas of expertise are Ascites, Portal Hypertension, Esophageal Varices, Liver Transplant, and Endoscopy.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 24 articles and participated in 1 clinical trial in the study of Liver Failure.

Gender
Male

Locations

CHU Caen
Caen, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study
Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study
Enrollment Status: Recruiting
Publish Date: April 30, 2024
Intervention Type: Dietary supplement
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis
Clinical Study of the BreathID® LF System to Train the Algorithm for the ¹³C-Methacetin Breath Test (MBT) in Assessment of Portal Hypertension in Patients With Compensated Liver Cirrhosis
Enrollment Status: Completed
Publish Date: December 20, 2022
Intervention Type: Device
Study Phase: Not Applicable
Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
Enrollment Status: Completed
Publish Date: March 26, 2021
Intervention Type: Other
Using MRI for a Non-invasive Evaluation of Portal Pressure
Using MRI for a Non-invasive Evaluation of Portal Pressure
Enrollment Status: Terminated
Publish Date: August 21, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 5 Less Clinical Trials

171 Total Publications

Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial.
Journal: The lancet. Gastroenterology & hepatology
Published: March 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bureau's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 35 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile